|
BR9708246A
(pt)
*
|
1996-03-25 |
1999-07-27 |
Lilly Co Eli |
Metodo para tratamento de dor
|
|
EP0906104A4
(en)
|
1996-03-25 |
2003-12-10 |
Lilly Co Eli |
PAIN TREATMENT PROCESS
|
|
JP2000507546A
(ja)
*
|
1996-03-25 |
2000-06-20 |
イーライ・リリー・アンド・カンパニー |
麻酔方法
|
|
ZA977967B
(en)
*
|
1996-09-23 |
1999-03-04 |
Lilly Co Eli |
Combination therapy for treatment of psychoses
|
|
US20030133974A1
(en)
*
|
1997-07-01 |
2003-07-17 |
Curatolo William John |
Encapsulated solution dosage forms of sertraline
|
|
US20040208926A1
(en)
*
|
1997-07-01 |
2004-10-21 |
Pfizer Inc |
Solubilized sertraline compositions
|
|
PL337806A1
(en)
|
1997-07-01 |
2000-09-11 |
Pfizer |
Sertralin salts and sertalin dosage forms of prolonged release
|
|
CZ20004279A3
(cs)
*
|
1998-05-22 |
2001-09-12 |
Eli Lilly And Company |
Lék pro léčení nepoddajné deprese a farmaceutická kompozice
|
|
US6960577B2
(en)
|
1998-05-22 |
2005-11-01 |
Eli Lilly And Company |
Combination therapy for treatment of refractory depression
|
|
CZ20004280A3
(cs)
*
|
1998-05-29 |
2001-09-12 |
Eli Lilly And Company |
Lék pro léčbu bipolárních poruch a farmaceutický prostředek
|
|
JP2002524513A
(ja)
*
|
1998-09-15 |
2002-08-06 |
イーライ・リリー・アンド・カンパニー |
持続痛の治療
|
|
EP2087892A3
(en)
|
1999-07-01 |
2009-09-30 |
Pharmacia & Upjohn Company LLC |
(S,S) reboxetine for treating age associated learning and mental disorders
|
|
CN1251758C
(zh)
*
|
2000-07-21 |
2006-04-19 |
特瓦制药工业有限公司 |
丙戊酸和2－丙基戊烯酸酰胺的衍生物在制备治疗双极情感障碍症躁狂病药物中的用途
|
|
MXPA03001458A
(es)
*
|
2000-08-17 |
2004-05-04 |
Teva Pharma |
Derivados de acido valproico para el tratamiento del dolor.
|
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
|
WO2003066039A1
(en)
*
|
2002-02-08 |
2003-08-14 |
Abbott Laboratories |
Combination therapy for treatment of schizophrenia
|
|
JP2005522445A
(ja)
*
|
2002-02-12 |
2005-07-28 |
サイプレス バイオサイエンス， インコーポレイテッド |
注意欠陥過活動性障害（ａｄ／ｈｄ）の処置方法
|
|
JP2005523334A
(ja)
*
|
2002-04-24 |
2005-08-04 |
サイプレス バイオサイエンス， インコーポレイテッド |
ストレス関連障害を含む機能的身体障害の予防および処置
|
|
US6881829B2
(en)
*
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
|
WO2003101492A2
(en)
*
|
2002-05-30 |
2003-12-11 |
Neurosearch A/S |
Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain
|
|
US20040106681A1
(en)
*
|
2002-10-03 |
2004-06-03 |
Cypress Bioscience, Inc. |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
|
ATE420647T1
(de)
|
2002-11-26 |
2009-01-15 |
Alexza Pharmaceuticals Inc |
Verwendung von loxapine für die herstellung eines mittels zur behandlung von schmerz
|
|
JP2006514633A
(ja)
*
|
2002-11-26 |
2006-05-11 |
アレックザ ファーマシューティカルズ， インコーポレイテッド |
吸入によって送達される抗精神病薬を用いた頭痛の治療
|
|
KR100842694B1
(ko)
|
2002-12-27 |
2008-07-01 |
오쓰까 세이야꾸 가부시키가이샤 |
기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제
|
|
AR042806A1
(es)
*
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
|
US7531543B2
(en)
|
2003-10-14 |
2009-05-12 |
Wyeth |
Phenylpiperazine cycloalkanol derivatives and methods of their use
|
|
US7402698B2
(en)
|
2003-10-14 |
2008-07-22 |
Wyeth |
Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
|
|
US7550485B2
(en)
|
2003-10-14 |
2009-06-23 |
Wyeth |
Substituted N-heterocycle derivatives and methods of their use
|
|
US7365076B2
(en)
|
2003-10-14 |
2008-04-29 |
Wyeth |
Substituted aryl cycloalkanol derivatives and methods of their use
|
|
US7419980B2
(en)
|
2003-10-14 |
2008-09-02 |
Wyeth |
Fused-aryl and heteroaryl derivatives and methods of their use
|
|
US7491723B2
(en)
|
2003-10-14 |
2009-02-17 |
Wyeth |
Alkanol and cycloalkanol-amine derivatives and methods of their use
|
|
US7524846B2
(en)
|
2003-10-14 |
2009-04-28 |
Wyeth |
Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
|
|
DE102004011392A1
(de)
*
|
2004-01-13 |
2005-08-04 |
Grünenthal GmbH |
Schwache bis mittelstarke Opioide oder Kombinationen dieser Opioide mit Antidepressiva für die Behandlung von Depressionen, Angststörungen und Schmerzen
|
|
US7414052B2
(en)
|
2004-03-30 |
2008-08-19 |
Wyeth |
Phenylaminopropanol derivatives and methods of their use
|
|
US7517899B2
(en)
|
2004-03-30 |
2009-04-14 |
Wyeth |
Phenylaminopropanol derivatives and methods of their use
|
|
TWI432196B
(zh)
*
|
2005-01-18 |
2014-04-01 |
Euro Celtique Sa |
內臟痛的治療
|
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
EP1951643A1
(en)
*
|
2005-11-23 |
2008-08-06 |
Auspex Pharmaceuticals Inc. |
Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
|
|
US8551986B2
(en)
*
|
2005-12-08 |
2013-10-08 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
EP1988883A1
(fr)
*
|
2006-02-17 |
2008-11-12 |
Trimaran Limited |
Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions
|
|
US8536445B2
(en)
*
|
2006-06-02 |
2013-09-17 |
Emcore Solar Power, Inc. |
Inverted metamorphic multijunction solar cells
|
|
US20080102097A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Zanella John M |
Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
|
|
US20080026054A1
(en)
*
|
2007-04-27 |
2008-01-31 |
Nectid Inc. |
Novel anelgesic combination
|
|
US20080031950A1
(en)
*
|
2007-04-27 |
2008-02-07 |
Nectid Inc. |
Novel anelgesic combination
|
|
US8470360B2
(en)
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
|
WO2009126931A2
(en)
|
2008-04-11 |
2009-10-15 |
Xvasive, Inc. |
Combination therapy for bipolar disorder
|
|
US8557273B2
(en)
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US8956641B2
(en)
*
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
|
US8629172B2
(en)
*
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US8722079B2
(en)
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US8946277B2
(en)
*
|
2008-04-18 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Clonidine formulations in a biodegradable polymer carrier
|
|
US9610243B2
(en)
|
2008-04-18 |
2017-04-04 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
|
US9072727B2
(en)
*
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
|
US20090263489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
|
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
|
US8822546B2
(en)
*
|
2008-12-01 |
2014-09-02 |
Medtronic, Inc. |
Flowable pharmaceutical depot
|
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
|
US20100239632A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
US8617583B2
(en)
*
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US8231891B2
(en)
*
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
|
CN112451477B
(zh)
|
2011-03-18 |
2022-12-30 |
奥克梅斯制药爱尔兰有限公司 |
包含脱水山梨糖醇酯的药物组合物
|
|
GB2524689B
(en)
|
2011-05-20 |
2016-01-27 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
AU2013235519C1
(en)
*
|
2012-03-19 |
2018-04-26 |
Alkermes Pharma Ireland Limited |
Pharmaaceutical compositions comprising fatty acid esters
|
|
CA2867123C
(en)
|
2012-03-19 |
2021-02-16 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising water-insoluble antipsychotic agents and glycerol esters
|
|
EP2827866B1
(en)
|
2012-03-19 |
2023-05-03 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
|
NZ631345A
(en)
|
2012-09-19 |
2017-06-30 |
Alkermes Pharma Ireland Ltd |
Pharmaceutical compositions having improved storage stability
|
|
EP4082550A1
(en)
|
2013-12-24 |
2022-11-02 |
DURECT Corporation |
Use of oxygenated cholesterol sulfates (ocs) for treating acute liver failure
|
|
EP3119399A4
(en)
|
2014-03-20 |
2017-09-27 |
Alkermes Pharma Ireland Limited |
Aripiprazole formulations having increased injection speeds
|
|
EP3468540A4
(en)
*
|
2016-06-13 |
2020-03-18 |
Board Of Regents Of the University Of Texas System |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
|
|
US11273158B2
(en)
|
2018-03-05 |
2022-03-15 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
CN113272298B
(zh)
*
|
2018-11-07 |
2025-04-18 |
天莅生物技术有限公司 |
用于治疗呼吸系统疾病的化合物和组合物
|